Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes
Anticancer Research · 2025
DOI: 10.21873/anticanres.17858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yusuke Ishigami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Cisplatin, Sodium-Glucose Transporter 2 Inhibitors, Acute Kidney Injury, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan.
- Department of Pharmacy, Osaka Metropolitan University Hospital, Osaka, Japan; masaya-tak@umin.ac.jp.
- Department of Quality and Safety Management, Osaka Metropolitan University Hospital, Osaka, Japan.
- Department of Infection control, Osaka Metropolitan University Hospital, Osaka, Japan.
Zitieren
APA
Ishigami, Y., Takahashi, M., Nakatsukasa, H., Nishiura, H., Kohara, Y., & Nakamura, Y. (2025). Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes. Anticancer Research. https://doi.org/10.21873/anticanres.17858
Vancouver
Ishigami Y, Takahashi M, Nakatsukasa H, Nishiura H, Kohara Y, Nakamura Y. Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes. Anticancer Research. 2025. doi:10.21873/anticanres.17858
BibTeX
@article{Ishigami2025,
author = {Ishigami, Yusuke and Takahashi, Masaya and Nakatsukasa, Hitomi and Nishiura, Hironobu and Kohara, Yuya and Nakamura, Yasutaka},
title = {Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17858}
}
EUVIMED